FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Robert Meineke, Sonja Stelz, Maximilian Busch, Christopher Werlein, Mark Kühnel, Danny Jonigk, Guus F. Rimmelzwaan, Husni Elbahesh

Journal title: iScience

Journal number: 26

Journal publisher: MDPI

Published year: 2024

Published pages: 106309

DOI identifier: 10.1016/j.isci.2023.106309

ISSN: 2589-0042